Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

<ul><li>Abbott has demonstrated robust performance in its third quarter of 2024 with an organic sales growth of over 8%, excluding COVID testing sales, and adjusted earnings per share of $1.21.</li><li>These results underscore the company's capacity to execute its multifaceted strategy effectively, despite varying performance across different sectors.</li><li>Notably, the U.S. Pediatric Nutrition segment showed remarkable growth, leading with a 12% increase due to gains in the infant formula business.</li></ul>

Abbott has demonstrated robust performance in its third quarter of 2024 with an organic sales growth of over 8%, excluding COVID testing sales, and adjusted earnings per share of $1.21.These results underscore the company's capacity to execute its multifaceted strategy effectively, despite varying performance across different sectors.Notably, the U.S. Pediatric Nutrition segment showed remarkable growth, leading with a 12% increase due to gains in the infant formula business.

Abbott Laboratories: A Tale Of Pipeline Productivity and Innovation! - Major Drivers

AutoZone, Inc. is a specialty retailer of automotive replacement parts and accessories. The Company offers an extensive product line for cars, sport utility vehicles, vans and light trucks, including new and remanufactured automotive hard parts, maintenance items, accessories and non-automotive products.  Autozone operates in United States and Puerto Rico, and Mexico.

<ul><li>AutoZone, Inc. delivered a robust performance in the fourth quarter of the fiscal year 2024, led by significant sales increases and growth strategies in both its domestic and international operations.</li><li>The company's total sales surged by 9% in the fourth quarter, while earnings per share (EPS) increased by 11%.</li><li>Underpinning these results was a consistent focus on customer service excellence and strategic expansion, particularly in commercial sales and international operations.</li></ul>

AutoZone, Inc. delivered a robust performance in the fourth quarter of the fiscal year 2024, led by significant sales increases and growth strategies in both its domestic and international operations.The company's total sales surged by 9% in the fourth quarter, while earnings per share (EPS) increased by 11%.Underpinning these results was a consistent focus on customer service excellence and strategic expansion, particularly in commercial sales and international operations.

AutoZone Inc.: Tackling The International Market Dynamics & FX Impact! - Major Drivers

Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company's products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

<ul><li>Boston Scientific Corporation presented its third quarter of 2024 financial results, reflecting a strong performance that exceeded company forecasts and investor expectations.</li><li>The corporation reported a significant growth in operational sales by 19% and organic sales by 18%, surpassing the anticipated guidance range of 13% to 15%.</li><li>Adjusted earnings per share (EPS) grew by 27% to $0.63, also exceeding the projections of $0.57 to $0.59.</li></ul>

Boston Scientific Corporation presented its third quarter of 2024 financial results, reflecting a strong performance that exceeded company forecasts and investor expectations.The corporation reported a significant growth in operational sales by 19% and organic sales by 18%, surpassing the anticipated guidance range of 13% to 15%.Adjusted earnings per share (EPS) grew by 27% to $0.63, also exceeding the projections of $0.57 to $0.59.

Boston Scientific's Game-Changing Farapulse Tech: How It's Revolutionizing Atrial Fibrillation Treatment!: - Major Drivers

Teledyne Technologies Inc. provides electronic subsystems and instrumentation. The Company provides aerospace and defense electronics, digital imaging products & software, monitoring instrumentation for marine & environmental applications, harsh environment interconnect products, and subsystems for satellite communications.  Teledyne also provides engineered systems.

<ul><li>Teledyne Technologies Incorporated reported an impressive performance for the third quarter of 2024, achieving all-time record sales with growth in each business segment.</li><li>This growth was fueled by robust demand in their longer-cycle defense, space, and energy sectors, though sales in most short-cycle commercial businesses have either stabilized or begun to recover sequentially.</li><li>The company continued aggressive capital management strategies during the quarter, including repurchasing approximately $354 million of its stock, completing two acquisitions valued at $125 million, and repaying $450 million in gross debt.</li></ul>

Teledyne Technologies Incorporated reported an impressive performance for the third quarter of 2024, achieving all-time record sales with growth in each business segment.This growth was fueled by robust demand in their longer-cycle defense, space, and energy sectors, though sales in most short-cycle commercial businesses have either stabilized or begun to recover sequentially.The company continued aggressive capital management strategies during the quarter, including repurchasing approximately $354 million of its stock, completing two acquisitions valued at $125 million, and repaying $450 million in gross debt.

Teledyne Technologies: Can They Capitalize On The Strengthening Defense & Energy Markets? - Major Drivers

Valero Energy Corporation is an independent petroleum refining and marketing company that owns and operates refineries in the United States, Canada, and Aruba.  The Company produces conventional gasolines, distillates, jet fuel, asphalt, petrochemicals, lubricants, and other refined products as well as diesel fuel, low-sulfur and ultra-low-sulfur diesel fuel, and oxygenates.

<ul><li>Valero Energy Corporation recently disclosed its financial performance for the third quarter of 2024.</li><li>The earnings report highlighted various aspects of the company’s operational and financial status, presenting a mixed set of results impacted by significant maintenance activities and a challenging margin environment.</li><li>During the quarter, Valero's refineries operated at 90% of their throughput capacity, in line with previous guidance, despite a period of heavy maintenance.</li></ul>

Valero Energy Corporation recently disclosed its financial performance for the third quarter of 2024.The earnings report highlighted various aspects of the company’s operational and financial status, presenting a mixed set of results impacted by significant maintenance activities and a challenging margin environment.During the quarter, Valero's refineries operated at 90% of their throughput capacity, in line with previous guidance, despite a period of heavy maintenance.

Valero Energy Corporation: An Insight Into The Impact of International Trade and Market Dynamics! - Major Drivers